A carregar...
Survival in melanoma brain metastases in the era of novel systemic therapies
BACKGROUND: Melanoma brain metastases (MBMs) have historically poor overall survival (OS). Recently introduced systemic anticancer therapies (SACTs), namely targeted therapies such as BRAF inhibitors and immunotherapy, to control advanced disease have shown improved survival. Today, increasingly agg...
Na minha lista:
| Publicado no: | Neurooncol Adv |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7764504/ https://ncbi.nlm.nih.gov/pubmed/33392503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa144 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|